(Q40138577)

17 September 2017

Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer (English)

1 reference

17 September 2017

Reiko Kaneko

1

1 reference

17 September 2017

Naoki Tsuji

2

1 reference

17 September 2017

Koichi Asanuma

3

1 reference

17 September 2017

Hiromi Tanabe

4

1 reference

17 September 2017

Daisuke Kobayashi

5

1 reference

17 September 2017

Naoki Watanabe

6

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Journal of Biological Chemistry

17 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 September 2017

282

1 reference

17 September 2017

19273-19281

1 reference

17 September 2017

27

1 reference

Isoprenoids influence expression of Ras and Ras-related proteins

17 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

All ras proteins are polyisoprenylated but only some are palmitoylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Increasing complexity of the Ras signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

A role for survivin in radioresistance of pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Mitotic kinases as regulators of cell division and its checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Regulation of Bcl-xL: a little bit of this and a little bit of STAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Sp1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610350200

21 January 2018

Identifiers

DOI

10.1074/JBC.M610350200

1 reference

17 September 2017

1 reference